Tenet Healthcare (THC) Tops Q3 EPS by $1.03, Guidance Beats

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $1.99, $1.03 better than the analyst estimate of $0.96. Revenue for the quarter came in at $4.89 billion versus the consensus estimate of $4.77 billion.

GUIDANCE:

Tenet Healthcare sees FY2021 EPS of $6.15-$6.38, versus the consensus of $5.57.

• Adjusted EBITDA Outlook range now $3.275 billion to $3.325 billion (previously $3.150 billion to $3.250 billion)

• Net operating revenues $19.5 to $19.8 billion

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
• Hexcel falls on revenue miss and weak guidance
• Oceaneering (OII) Misses Q3 EPS by 9c